CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 74 enrolled
Drug / intervention
Activa Dose II Real tDCS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01686373
NCT01686373Phase 2Completed

Transcranial Direct Current Stimulation and Aphasia Treatment Outcomes

University of South Carolina·interventional·Posted Sep 18, 2012·Updated Aug 20, 2019

In Brief

A Phase 2 clinical trial evaluating Activa Dose II Real tDCS and Activa Dose II Sham tDCS for Aphasia. Completed, enrolled 74 participants across 2 sites.

Detailed Summary

The purpose of this study is to assess the changes in language processing of patients with chronic, post-stroke aphasia following the application of brain stimulation. The brain stimulation the investigators administer is called transcranial direct current stimulation (tDCS). It involves passing a weak electrical current through the brain between two electrodes in the form of damp sponges. One sponge will be placed over a specified area on the damaged left hemisphere, while the other sponge will be placed on the right scalp. Computer-controlled speech-language treatment will be administered during the application of tDCS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAphasia
CountriesUnited States

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 18, 2012
Enrollment StartApr 1, 2012
Primary CompletionMay 1, 2017
Study CompletionOct 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 13.8 years ago

Interventions

Activa Dose II Real tDCSdevice

20 minutes of 1 milliamp active tDCS per treatment day (15 total sessions)

Activa Dose II Sham tDCSdevice

20 minutes of sham stimulation per treatment day (15 total sessions)